CLINICAL ROLE -
Treatment of Diabetes and Angioedema Risk
Pharmacists must be aware of potentially serious adverse reactions in patients receiving angiotensin- converting enzyme therapy, particularly with the concurrent use of dipeptidly peptidase IV inhibitors.
Read More